Nordea Investment Management’s Sangamo Therapeutics SGMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-640,346
| Closed | -$1.11M | – | 974 |
|
|
2023
Q1 | $1.11M | Sell |
640,346
-33,052
| -5% | -$57.5K | ﹤0.01% | 768 |
|
|
2022
Q4 | $2.03M | Sell |
673,398
-8,714
| -1% | -$26.2K | ﹤0.01% | 670 |
|
|
2022
Q3 | $3.43M | Buy |
682,112
+1,000
| +0.1% | +$5.03K | 0.01% | 596 |
|
|
2022
Q2 | $2.74M | Buy |
681,112
+32,682
| +5% | +$131K | ﹤0.01% | 652 |
|
|
2022
Q1 | $3.94M | Buy |
648,430
+32,988
| +5% | +$201K | ﹤0.01% | 623 |
|
|
2021
Q4 | $4.84M | Sell |
615,442
-11,054
| -2% | -$86.9K | 0.01% | 595 |
|
|
2021
Q3 | $5.84M | Sell |
626,496
-11,394
| -2% | -$106K | 0.01% | 578 |
|
|
2021
Q2 | $7.64M | Buy |
637,890
+57,722
| +10% | +$691K | 0.01% | 479 |
|
|
2021
Q1 | $7.16M | Buy |
580,168
+19,580
| +3% | +$242K | 0.01% | 455 |
|
|
2020
Q4 | $8.75M | Buy |
560,588
+228,077
| +69% | +$3.56M | 0.01% | 380 |
|
|
2020
Q3 | $3.28M | Sell |
332,511
-327,537
| -50% | -$3.23M | 0.01% | 591 |
|
|
2020
Q2 | $5.83M | Buy |
660,048
+335,542
| +103% | +$2.97M | 0.01% | 595 |
|
|
2020
Q1 | $2.11M | Buy |
324,506
+7,504
| +2% | +$48.7K | 0.01% | 643 |
|
|
2019
Q4 | $2.63M | Buy |
317,002
+16,609
| +6% | +$138K | 0.01% | 676 |
|
|
2019
Q3 | $2.74M | Buy |
300,393
+2,126
| +0.7% | +$19.4K | 0.01% | 680 |
|
|
2019
Q2 | $3.21M | Sell |
298,267
-10,450
| -3% | -$113K | 0.01% | 659 |
|
|
2019
Q1 | $2.95M | Sell |
308,717
-6,970
| -2% | -$66.5K | 0.01% | 795 |
|
|
2018
Q4 | $3.63M | Sell |
315,687
-2,232
| -0.7% | -$25.6K | 0.01% | 670 |
|
|
2018
Q3 | $5.39M | Buy |
317,919
+125,903
| +66% | +$2.13M | 0.01% | 532 |
|
|
2018
Q2 | $2.73M | Buy |
192,016
+71,723
| +60% | +$1.02M | 0.01% | 705 |
|
|
2018
Q1 | $2.29M | Buy |
+120,293
| New | +$2.29M | 0.01% | 726 |
|